Literature DB >> 6367164

Successful removal and prevention of resynthesis of anti-HLA antibody.

D H Taube, K I Welsh, L A Kennedy, M G Thick, M Bewick, J S Cameron, C S Ogg, C J Rudge, D G Williams.   

Abstract

The successful removal and prevention of the resynthesis of an anti-HLA antibody by plasma exchange and immunosuppression in a patient awaiting renal transplantation is described. Before treatment, the patient's serum contained a high titer (greater than 1/50) anti-HLA antibody that reacted with 94% of our lymphocyte donor panel and produced positive cross matches with the lymphocytes from 40 cadaver kidneys. Following treatment, her anti-HLA titers fell to less than 1/10 and her sera reacted with 43% of our lymphocyte donor panel and produced negative crossmatches with lymphocytes from the first two cadaver kidney donors she was tested against. She was successfully transplanted with the second of these kidneys and is now well eight months later, with good graft function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367164     DOI: 10.1097/00007890-198403000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Glomerular thrombi in renal allografts associated with cyclosporin treatment.

Authors:  G H Neild; R Reuben; R B Hartley; J S Cameron
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

2.  IMPORTANCE OF DONOR SELECTION IN RENAL TRANSPLANTATION.

Authors:  N K Mehra; G S Chopra
Journal:  Med J Armed Forces India       Date:  2017-06-27

3.  HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation.

Authors:  Nithya Krishnan; Aisha Abimbola; Nandhini Machan; Sunil Daga; Kishore Gopalakrishnan; ForTai Lam; LamChin Tan; Habib Kashi; Christopher Imray; Daniel Zehnder; Claire Collins; Rebecca Curtis; Robert Higgins; Natasha Khovanova; David Briggs
Journal:  Transplant Direct       Date:  2021-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.